Do raised cardiac markers following percutaneous coronary intervention really reflect cardiac necrosis? by Selvanayagam, J, Porto, I, Petersen, SE, Channon, K, Neubauer, S, Banning, A

Do raised cardiac markers following percutaneous coronary intervention (PCI) really reflect cardiac necrosis by Selvanayagam, J, Porto, I, Petersen, SE, Channon, K, Neubauer, S, Banning, A

Redundancy and evolution of GATA factor requirements in development of the myocardium. by Peterkin, T, Gibson, A, Patient, R

“…Using morpholinos in both Xenopus and zebrafish embryos, we show that GATA4 knockdown, for example, only affects cardiac marker expression in the absence of either GATA5 or GATA6. …”

Peri-operative troponin I concentration as a marker of long-term postoperative adverse cardiac outcomes--a study in high-risk surgical patients. by Higham, H, Sear, J, Sear, Y, Kemp, M, Hooper, R, Foex, P

“…We have previously demonstrated that the peri-operative measurement of increased serum concentrations of the cardiac markers troponins I and T and creatine kinase-MB can be predictors of major cardiovascular outcomes (including cardiac death) at 3 months after surgery. …”

5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. by Martin-Rendon, E, Sweeney, D, Lu, F, Girdlestone, J, Navarrete, C, Watt, S

“…While a small proportion (approximately 0.07%) of bone marrow MSCs could generate cardiomyocyte-like cells in vitro, those from umbilical cord and cord blood did not express cardiac markers either spontaneously or after treatment with 5-azacytidine. …”